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in H&E stained sections. Area of CCD was divided by total artic-
ular cartilage area to generate a percentage. In addition, a larger
group of joints (n=158), including all joints from the present study,
was evaluated using a comprehensive histological grading scheme
composed of both semi quantitative grades and continuous mea-
surements (Study 2). The data from the medial tibial plateaus was
then subjected to Principal Components Analysis with one of the
resulting factors being weighted by the following variables: total
chondrocyte area, percentage of area of chondrocyte cell death,
total number of viable chondrocytes, total articular cartilage area
per viable chondrocyte, viable articular cartilage area per viable
chondrocyte. From the factor analysis, individual factor scores for
the joints evaluated in Study 2 were generated. The mean per-
cent CCD areas and the individual factor scores from the factor
weighted by variables relevant to CCD were evaluated by ANOVA
with age as the independent variable.
Results: The results from Study 1 revealed signiﬁcant differences
in percentage of CCD within the articular cartilage in the medial
tibial plateaus vs. age, with similar trends in the lateral tibial
plateaus. The youngest mice had the smallest area of CCD and
this progressively increased with age (Fig. 1). All comparisons
were signiﬁcant except for those involving the 16 month old mice,
which were not signiﬁcantly different from any of the other age
groups. The data using the factor score for CCD were closely
similar (Fig. 2).
Figure 1. % CCD by Age.
Figure 2. Average Factor Score, chondrocyte cell death.
Conclusions: Increased area of chondrocyte cell death with age
in murine articular cartilage has not previously been reported and
is an important consideration in studies of aging and osteoarthritis
in this species.
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Purpose: Glucocorticoids are widely used for treatment of
rheumatoid arthritis to suppress inﬂammation. Little is known
about their action on cartilage metabolism and the therapeutic
efﬁcacy for treatment of osteoarthritis (OA), although they have
adverse effects on other connective tissues, such as skin and
bone. The effects of the synthetic glucocorticoid dexamethasone
(Dex) on cartilage degradation were investigated by examining ag-
grecan catabolism and expression of aggrecanases (a disintegrin
and metalloproteinase with thrombospondin motifs (ADAMTS)-4
and -5) and collagenase (matrix metalloproteinase (MMP)-13) in
human, porcine and mouse articular cartilage.
Methods: Rested articular cartilage explants from human, porcine
or mouse joints were stimulated with either interleukin (IL)-1 or
retinoic acid (RetA) in the presence or absence of Dex (1, 10,
100 nM) with or without RU-486 (a glucocorticoid receptor an-
tagonist). Aggrecan degradation was quantiﬁed by measuring the
release of glycosaminoglycan (GAG) and aggrecanase-dependent
aggrecan fragments by Western blotting with neo-epitopes anti-
bodies for AR/LGS and AGEG. The expression of ADAMTS-4, -5,
MMP-13 and cyclooxygenase (COX)-2 mRNAs was measured by
quantitative real-time PCR.
Results: IL-1 caused aggrecan degradation with the release of
GAG and aggrecanase-dependent aggrecan fragments (AR/LGS
and AGEG) and induction of ADAMTS-4, -5, MMP-13 and COX-
2 mRNA in all species tested. The induction of aggrecanase-
dependent aggrecan degradation was suppressed by Dex in hu-
man, accelerated in porcine and unaltered in mouse cartilage ex-
plants. Dex inhibited the induction of ADAMTS-5 but not ADAMTS-
4 mRNA in human, augmented both ADAMTS-4 and ADAMTS-5
mRNA in porcine and inhibited ADAMTS-4 but not ADAMTS-5
mRNA in mouse cartilage. Dex inhibited the IL-1-induction of
MMP-13 and COX-2 mRNA in all species as expected.
RetA caused aggrecan degradation and induction of ADAMTS-5
mRNA in all species and they were also inhibited by Dex in human,
enhanced in porcine and unaffected in mouse cartilage.
Actions of Dex were reversed by pretreating cartilage with RU-486
in all species.
Conclusions: Our ﬁndings suggest that glucocorticoids may be
therapeutically beneﬁcial by inhibiting aggrecan degradation and
induction of ADAMTS-5 mRNA expression in human articular
cartilage. In marked contrast, Dex did not inhibit aggrecanolysis in
mouse cartilage and further accelerated it in porcine tissue. These
species differences need to be carefully considered when working
on the regulation of aggrecan catabolism by aggrecanases.
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Purpose: Osteoarthritis (OA) is characterized by cartilage degra-
dation. Changes in TGF-beta superfamily signaling regulate chon-
drocyte differentiation and play a role in OA development. The
major TGF-beta signaling route is via Smads, Smad1/5/8 repre-
sent the so-called BMP route and Smad2/3 the TGF-beta route.
We have shown that Smad2/3 signaling was reduced in OA. In
contrast, BMP2, known to stimulate Smad1/5/8 signaling, was
elevated nearby OA lesions. We studied whether BMP-2 expres-
sion is related to diminished Smad2/3 signaling and explored the
potential biological signiﬁcance of BMP-2 neighboring OA lesions.
Methods: C57Bl/6 mice were injected with Ad-BMP-2 i.a. Knee
joints were isolated for histology 3 and 7 days after injection
and stained for Smad2/3P, and aggrecan degradation neoepitopes
VDIPEN and NITEGE. The impact of elevated BMP2 was investi-
gated in chondrocytes in culture, stimulated with Ad-BMP-2. RNA
was isolated for Q-PCR analysis.
As BMP2 reduced Smad2/3, we investigated the effect of reduced
Smad2/3 signaling on Smad1/5/8 signaling by exposing chondro-
cytes to SB-505124, an ALK5 inhibitor, followed by Western Blot
analysis of Smad2/3P and Smad1/5/8P.
To elucidate whether BMP2 modulates effects of TGF-
beta/Smad2/3 signaling in cartilage, we injected C57Bl/6 murine
